Citation: Rb. Forbes et al., Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis, BR MED J, 319(7224), 1999, pp. 1529-1533
Citation: Rb. Forbes et al., The prevalence of multiple sclerosis in Tayside, Scotland: do latitudinal gradients really exist?, J NEUROL, 246(11), 1999, pp. 1033-1040
Citation: Rb. Forbes et Rj. Swingler, Utilisation and costs of profession care and assistance according to disability of patients with multiple sclerosis in Flanders (Belgium), J NE NE PSY, 66(2), 1999, pp. 256-257
Citation: Rb. Forbes et Rj. Swingler, Estimating the prevalence of multiple sclerosis in the United Kingdom by using capture-recapture methodology, AM J EPIDEM, 149(11), 1999, pp. 1016-1024